SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

SEC Comment Letter 0000000000-23-002763 to HAWKINS INC (HWKN) (CIK 0000046250) (HWKN)

HAWKINS INC (HWKN) (CIK 0000046250)
Date: March 20, 2023 · CIK: 0000046250 · Accession: 0000000000-23-002763

AI Filing Summary & Sentiment

File numbers found in text: 000-07647

Date
March 20, 2023
Author
Not clearly detected
Form
UPLOAD
Company
HAWKINS INC (HWKN) (CIK 0000046250)

Letter

United States securities and exchange commission logo March 20, 2023 Jeffrey Oldenkamp Executive Vice President and Chief Financial Officer Hawkins, Inc. 2381 Rosegate Roseville, MN 55113 Re:Hawkins, Inc. Form 10-K for the Fiscal Year Ended April 3, 2022 Filed May 18, 2022 File No. 000-07647 Dear Jeffrey Oldenkamp: We have limited our review of your filing to the financial statements and related disclosures and have the following comment. In our comment, we may ask you to provide us with information so we may better understand your disclosure. Please respond to the comment within ten business days by providing the requested information or advise us as soon as possible when you will respond. If you do not believe our comment applies to your facts and circumstances, please tell us why in your response. After reviewing your response to these comments, we may have additional comments. Form 10-K for the Fiscal Year Ended April 3, 2022 Management's Discussion and Analysis of Financial Condition and Results of Operations Results of Operations Fiscal 2022 Compared to Fiscal 2021 Sales, page 16 1.Please quantify factors to which changes are attributed, including the impact of changes in the selling prices of your products and changes in the volume of goods sold. We note you quantify bulk commodity products as a percent of sales. Please explain the importance of this to an investor's understanding of your results. Please consider quantifying increases in your sales by product lines in your segment sales discussion if important to investor's understanding. Refer to Item 303(b)(2)(iii) of Regulation S-K. In closing, we remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or

FirstName LastNameJeffrey Oldenkamp Comapany NameHawkins, Inc. March 20, 2023 Page 2 FirstName LastName Jeffrey Oldenkamp Hawkins, Inc. March 20, 2023 Page 2 absence of action by the staff. You may contact Robert Shapiro at 202-551-3273 or Lyn Shenk at 202-551-3380 with any questions. Sincerely, Division of Corporation Finance Office of Trade & Services

Show Raw Text
United States securities and exchange commission logo
March 20, 2023
Jeffrey Oldenkamp
Executive Vice President and Chief Financial Officer
Hawkins, Inc.
2381 Rosegate
Roseville, MN 55113
Re:Hawkins, Inc.
Form 10-K for the Fiscal Year Ended April 3, 2022
Filed May 18, 2022
File No. 000-07647
Dear Jeffrey Oldenkamp:
            We have limited our review of your filing to the financial statements and related
disclosures and have the following comment.  In our comment, we may ask you to provide us
with information so we may better understand your disclosure.
            Please respond to the comment within ten business days by providing the requested
information or advise us as soon as possible when you will respond.  If you do not believe our
comment applies to your facts and circumstances, please tell us why in your response.
            After reviewing your response to these comments, we may have additional comments.
Form 10-K for the Fiscal Year Ended April 3, 2022
Management's Discussion and Analysis of Financial Condition and Results of Operations
Results of Operations
Fiscal 2022 Compared to Fiscal 2021
Sales, page 16
1.Please quantify factors to which changes are attributed, including the impact of changes in
the selling prices of your products and changes in the volume of goods sold.  We note
you quantify bulk commodity products as a percent of sales.  Please explain the
importance of this to an investor's understanding of your results. Please consider
quantifying increases in your sales by product lines in your segment sales discussion if
important to investor's understanding.  Refer to Item 303(b)(2)(iii) of Regulation S-K.
            In closing, we remind you that the company and its management are responsible for the
accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or

 FirstName LastNameJeffrey Oldenkamp
 Comapany NameHawkins, Inc.
 March 20, 2023 Page 2
 FirstName LastName
Jeffrey Oldenkamp
Hawkins, Inc.
March 20, 2023
Page 2
absence of action by the staff.
            You may contact Robert Shapiro at 202-551-3273 or Lyn Shenk at 202-551-3380 with
any questions.
Sincerely,
Division of Corporation Finance
Office of Trade & Services